Gain Therapeutics (GANX) EBT Margin (2020 - 2023)
Gain Therapeutics (GANX) posted quarterly EBT Margin of 9279.8% for Q1 2023, down 201195.0% year-over-year from N/an in Q1 2022, and up 94.56% quarter-over-quarter from 170666.04% in Q4 2022.
Gain Therapeutics (GANX) EBT Margin (2020 - 2023) Analysis & Trends
Gain Therapeutics' EBT Margin history runs 4 years deep, the most recent figure standing at 9279.8% for Q1 2023.
- In Q1 2023, EBT Margin fell 201195.0% year-over-year to 9279.8%; the TTM figure through Dec 2023 stood at 40735.22% (down 4061756.0% YoY), while the FY2023 annual figure was 40735.22%, down 4061756.0% from the prior year.
- EBT Margin for Q1 2023 stood at 9279.8%, up from 170666.04% in the prior quarter.
- The five-year high for EBT Margin was 4653.73% in Q2 2021, with the low at 170666.04% in Q4 2022.
- The 4-year median for EBT Margin is 10293.59% (2020), against an average of 27301.39%.
- Peak annual rise in EBT Margin reached 3917300 bps in 2022, while the deepest fall reached 14407918 bps in 2022.
- Gain Therapeutics' EBT Margin stood at 11307.39% in 2020, then plunged by 135 bps to 26586.86% in 2021, then sank by 542 bps to 170666.04% in 2022, then jumped by 95 bps to 9279.8% in 2023.
- Business Quant data shows GANX's EBT Margin at 9279.8% in Q1 2023, 170666.04% in Q4 2022, and 5337.72% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Gain Therapeutics | 85.12 Mn | 85.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -9,279.80% |
| Dec 31, 2022 | -170,666.04% |
| Jun 30, 2022 | -5,337.72% |
| Mar 31, 2022 | -7,267.84% |
| Dec 31, 2021 | -26,586.86% |
| Sep 30, 2021 | -17,035.72% |
| Jun 30, 2021 | -4,653.73% |
| Mar 31, 2021 | -46,440.84% |
| Dec 31, 2020 | -11,307.39% |
| Sep 30, 2020 | -11,850.15% |
| Jun 30, 2020 | -8,455.03% |
| Mar 31, 2020 | -8,735.52% |